Frazier Life Sciences Public Fund, L.p. - Net Worth and Insider Trading
Frazier Life Sciences Public Fund, L.p. Net Worth
The estimated net worth of Frazier Life Sciences Public Fund, L.p. is at least $27 Million dollars as of 2025-01-19. Frazier Life Sciences Public Fund, L.p. is the 10% Owner of Viridian Therapeutics Inc and owns about 1,505,200 shares of Viridian Therapeutics Inc (VRDN) stock worth over $27 Million. Details can be seen in Frazier Life Sciences Public Fund, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Frazier Life Sciences Public Fund, L.p. has not made any transactions after 2021-09-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Frazier Life Sciences Public Fund, L.p.
Frazier Life Sciences Public Fund, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frazier Life Sciences Public Fund, L.p. owns 1 companies in total, including Viridian Therapeutics Inc (VRDN) .
Insider Ownership Summary of Frazier Life Sciences Public Fund, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRDN | Viridian Therapeutics Inc | 2021-09-23 | 10 percent owner |
Frazier Life Sciences Public Fund, L.p. Latest Holdings Summary
Frazier Life Sciences Public Fund, L.p. currently owns a total of 1 stock. Frazier Life Sciences Public Fund, L.p. owns 1,505,200 shares of Viridian Therapeutics Inc (VRDN) as of September 23, 2021, with a value of $27 Million.
Latest Holdings of Frazier Life Sciences Public Fund, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics Inc | 2021-09-23 | 1,505,200 | 18.13 | 27,289,276 |
Holding Weightings of Frazier Life Sciences Public Fund, L.p.
Frazier Life Sciences Public Fund, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Frazier Life Sciences Public Fund, L.p. has made a total of 1 transactions in Viridian Therapeutics Inc (VRDN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Viridian Therapeutics Inc is the acquisition of 200,000 shares on September 23, 2021, which cost Frazier Life Sciences Public Fund, L.p. around $2 Million.
Insider Trading History of Frazier Life Sciences Public Fund, L.p.
- 1
Frazier Life Sciences Public Fund, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Frazier Life Sciences Public Fund, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frazier Life Sciences Public Fund, L.p. is 49.41%. GuruFocus also compares Frazier Life Sciences Public Fund, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Frazier Life Sciences Public Fund, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frazier Life Sciences Public Fund, L.p.'s insider trading performs compared to the benchmark.
Performance of Frazier Life Sciences Public Fund, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.44 | | | | | |
| Relative Return to S&P 500(%) | 10.28 | | | | | |
Frazier Life Sciences Public Fund, L.p. Ownership Network
Ownership Network List of Frazier Life Sciences Public Fund, L.p.
Ownership Network Relation of Frazier Life Sciences Public Fund, L.p.
Frazier Life Sciences Public Fund, L.p. Owned Company Details
What does Viridian Therapeutics Inc do?
Who are the key executives at Viridian Therapeutics Inc?
Frazier Life Sciences Public Fund, L.p. is the 10 percent owner of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & President and CEO Stephen F. Mahoney , Chief Operating Officer Thomas W. Beetham , and director & other: See Remarks Fairmount Healthcare Fund Ii Gp Llc .
Viridian Therapeutics Inc (VRDN) Insider Trades Summary
Over the past 18 months, Frazier Life Sciences Public Fund, L.p. made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net purchase of 1,600,000 shares made by Fairmount Healthcare Fund Ii Gp Llc , a net purchase of 476,190 shares made by Fairmount Healthcare Fund Gp Llc , and a net purchase of 21,400 shares made by Stephen F. Mahoney .
In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Viridian Therapeutics Inc (VRDN) were sold and 2,102,590 shares were bought by its insiders, resulting in a net purchase of 2,102,590 shares.
Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viridian Therapeutics Inc Insider Transactions
Frazier Life Sciences Public Fund, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Frazier Life Sciences Public Fund, L.p.. You might contact Frazier Life Sciences Public Fund, L.p. via mailing address: Two Union Square, 601 Union St., Suite 3200, Seattle Wa 98101.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
